Theravance Biopharma Inc.

NASDAQ: TBPH · Real-Time Price · USD
13.14
0.20 (1.55%)
At close: Aug 15, 2025, 3:59 PM
13.16
0.15%
After-hours: Aug 15, 2025, 06:33 PM EDT

Theravance Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-8.15 -11.26 -8.9 -3.85
PEG Ratio
-0.54 0.55 0.16 0.11
PS Ratio
7.14 10.82 16.08 13.88
PB Ratio
2.62 2.92 1.87 -2.27
P/FCF Ratio
-38.73 -21.08 -4.4 -3.63
P/OCF Ratio
-39.85 -23.02 -4.42 -3.69
OCF/S Ratio
-0.18 -0.47 -3.64 -3.76
Debt / Equity Ratio
0.28 0.23 0.17 -1.93
Quick Ratio
5.02 5.39 12.26 4.09
Current Ratio
5.02 5.39 12.31 4.26
Asset Turnover
0.18 0.15 0.08 0.15
Interest Coverage
-18.44 -23.84 -14.44 -30.16
Return on Equity
-0.32 -0.26 -0.21 0.59
Return on Assets
-0.16 -0.14 -0.15 -0.53
Return on Invested Capital
-0.18 -0.17 -0.16 -0.77
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 0.87 0.87
Net Profit Margin
-0.88 -0.96 -1.81 -3.61
Pretax Profit Margin
-0.69 -0.86 -1.81 -3.61
Operating Profit Margin
-0.73 -0.98 -1.79 -4.66
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.6 -0.74 -1.56 -4.51